Vestibular Migraine Prevention: Efficacy & Safety of Current Medications (2023 Evidence Review)

Vestibular migraine is a disabling health condition characterized by severe, recurrent attacks of vertigo. A Cochrane review assessed the benefits and potential harms of medications used to try to prevent these attacks. Key Facts: Only 3 small studies, with 209 participants in total, were identified that compared medications to placebo or no treatment The studies …

Read more

CGRP Antibodies & Migraine Prevention: Targeting Calcitonin Gene-Related Peptide

A new network meta-analysis published in Frontiers in Pharmacology provides important insights into the relative efficacy and safety of monoclonal antibodies targeting calcitonin gene-related peptide (CGRP) for migraine prevention. This comprehensive analysis compares four CGRP monoclonal antibodies – eptinezumab, erenumab, fremanezumab, and galcanezumab – and sheds light on which ones are most effective for reducing …

Read more